857
Views
0
CrossRef citations to date
0
Altmetric
Review

Application and Prospect of Metabolomics in the Early Diagnosis of Osteoporosis: A Narrative Review

ORCID Icon, , &
Pages 1369-1379 | Received 01 Jul 2023, Accepted 30 Aug 2023, Published online: 11 Sep 2023

References

  • Zou Z , LiuW, CaoLet al. Advances in the occurrence and biotherapy of osteoporosis. Biochem. Soc. Trans.48(4), 1623–1636 (2020).
  • Compston JE , McCclungMR, LeslieWD. Osteoporosis. Lancet 393(10169), 364–376 (2019).
  • Lv H , JiangF, GuanDet al. Metabolomics and its application in the development of discovering biomarkers for osteoporosis research. Int. J. Mol. Sci.17(12), (2016).
  • Prodhan MaI , ShiB, SongMet al. Integrating comprehensive two-dimensional gas chromatography mass spectrometry and parallel two-dimensional liquid chromatography mass spectrometry for untargeted metabolomics. Analyst144(14), 4331–4341 (2019).
  • Nicholson JK , LindonJC, HolmesE. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11), 1181–1189 (1999).
  • Kim HK , VerpoorteR. Sample preparation for plant metabolomics. PCA21(1), 4–13 (2010).
  • Liang KYH , FarjounY, ForgettaVet al. Predicting ExWAS findings from GWAS data: a shorter path to causal genes. Hum. Genet.142(6), 749–758 (2023).
  • Chong J , SoufanO, LiCet al. MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis. Nucleic Acids Res.46(W1), W486–W494 (2018).
  • Smilde AK , WesterhuisJA, HoefslootHCet al. Dynamic metabolomic data analysis: a tutorial review. Metabolomics6(1), 3–17 (2010).
  • Rendina-Ruedy E , RosenCJ. Lipids in the bone marrow: an evolving perspective. Cell Metab.31(2), 219–231 (2020).
  • Hu L , YinC, ZhaoF, AliA, MaJ, QianA. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int. J. Mol. Sci.19(2), 360 (2018).
  • Leung RYH , LiGHY, CheungBMY, TanKCB, KungAWC, CheungCL. Serum metabolomic profiling and its association with 25-hydroxyvitamin D. Clin. Nutr.39(4), 1179–1187 (2020).
  • Abshirini M , Ilesanmi-OyelereBL, KrugerMC. Potential modulatory mechanisms of action by long-chain polyunsaturated fatty acids on bone cell and chondrocyte metabolism. Prog. Lipid Res.83, 101113 (2021).
  • Aleidi SM , Al-AnsariMM, AlnehmiEAet al. Lipidomics profiling of patients with low bone mineral density (LBMD). Int. J. Mol. Sci.23(19), 12017 (2022).
  • Kou J , HeC, CuiLet al. Discovery of potential biomarkers for postmenopausal osteoporosis based on untargeted GC/LC–MS. Front. Endocrinol.13, 849076 (2022).
  • Yu L , QiH, AnGet al. Association between metabolic profiles in urine and bone mineral density of pre- and postmenopausal Chinese women. Menopause26(1), 94–102 (2019).
  • Ma B , LiuJ, ZhangQet al. Metabolomic profiles delineate signature metabolic shifts during estrogen deficiency-induced bone loss in rat by GC–TOF/MS. PLOS One8(2), e54965 (2013).
  • Li X , WangY, GaoMet al. Metabolomics-driven of relationships among kidney, bone marrow and bone of rats with postmenopausal osteoporosis. Bone156, 116306 (2022).
  • Sharma T , MandalCC. Omega-3 fatty acids in pathological calcification and bone health. J. Food Biochem.44(8), e13333 (2020).
  • Chen S , HeW. Metabolome-wide Mendelian randomization assessing the causal relationship between blood metabolites and bone mineral density. Calcif. Tissue Int.112(5), 543–562 (2023).
  • Van Der Veen JN , KennellyJP, WanS, VanceJE, VanceDE, JacobsRL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta Biomembr.1859(9 Pt B), 1558–1572 (2017).
  • Deng D , PanC, WuZet al. An integrated metabolomic study of osteoporosis: discovery and quantification of hyocholic acids as candidate markers. Front. Pharmacol.12, 725341 (2021).
  • Fang Y , ShenY, ZhangQet al. Exploring the mechanism of Jintiange capsule in preventing and treating osteoporosis based on UPLC–Q-TOF–MS metabolomics. Chinese Journal of Osteoporosis28(06), 848–856 (2022).
  • Mei Z , DongX, QianYet al. Association between the metabolome and bone mineral density in a Chinese population. EBioMedicine62, 103111 (2020).
  • Zhao H , LiX, ZhangDet al. Integrative bone metabolomics–lipidomics strategy for pathological mechanism of postmenopausal osteoporosis mouse model. Sci. Rep.8(1), 16456 (2018).
  • Lu X , ChenY, WangHet al. Integrated lipidomics and transcriptomics characterization upon aging-related changes of lipid species and pathways in human bone marrow mesenchymal stem cells. J. Proteome Res.18(5), 2065–2077 (2019).
  • Hanly R , RyanN, SnellingH, Walker-BoneK, DizdarevicS, PetersAM. Association between bile acid turnover and osteoporosis in postmenopausal women. Nucl. Med. Commun.34(6), 597–600 (2013).
  • Nehring JA , ZieroldC, DelucaHF. Lithocholic acid can carry out in vivo functions of vitamin D. Proc. Natl Acad. Sci. USA104(24), 10006–10009 (2007).
  • Qiao X , ZhangK, LiXet al. Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis. Front. Cell. Infect. Microbiol.12, 1018897 (2022).
  • Marchionatti A , RivoiraM, RodriguezV, PerezA, TolosaDe Talamoni N. Molecular mechanisms triggered by bile acids on intestinal Ca2+ absorption. Curr. Med. Chem.25(18), 2122–2132 (2018).
  • Chen JF , LinPW, TsaiYR, YangYC, KangHY. Androgens and androgen receptor actions on bone health and disease: from androgen deficiency to androgen therapy. Cells8(11), 1318 (2019).
  • Moayyeri A , CheungCL, TanKCet al. Metabolomic pathways to osteoporosis in middle-aged women: a genome-metabolome-wide Mendelian randomization study. J. Bone Miner. Res.33(4), 643–650 (2018).
  • Fujita S , VolpiE. Amino acids and muscle loss with aging. J. Nutr.136(Suppl. 1), S277–S280 (2006).
  • Panahi N , FahimfarN, RoshaniSet al. Association of amino acid metabolites with osteoporosis, a metabolomic approach: Bushehr elderly health program. Metabolomics18(8), 63 (2022).
  • Cui Z , FengH, HeB, HeJ, TianY. Relationship between serum amino acid levels and bone mineral density: a Mendelian randomization study. Front. Endocrinol.12, 763538 (2021).
  • Ling CW , MiaoZ, XiaoMLet al. The association of gut microbiota with osteoporosis is mediated by amino acid metabolism: multiomics in a large cohort. The J. Clin. Endocrinol. Metab.106(10), e3852–e3864 (2021).
  • Palacios-González B , Ramírez-SalazarEG, Rivera-ParedezBet al. A multi-omic analysis for low bone mineral density in postmenopausal women suggests a relationship between diet, metabolites, and microbiota. Microorganisms8(11), 1630 (2020).
  • Palacios-González B , León-ReyesG, Rivera-ParedezBet al. Serum metabolite profile associated with sex-dependent visceral adiposity index and low bone mineral density in a Mexican population. Metabolites11(9), 604 (2021).
  • Michalowska M , ZnorkoB, KaminskiT, Oksztulska-KolanekE, PawlakD. New insights into tryptophan and its metabolites in the regulation of bone metabolism. J. Physiol. Pharmacol.66(6), 779–791 (2015).
  • Ge F , WeiZ, CheYet al. Integrating untargeted and targeted metabolomics coupled with pathway analysis reveals muscle disorder in osteoporosis on orchiectomized mice. Molecules28(6), 2512 (2023).
  • Salminen A . Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process. Ageing Res. Rev.75, 101573 (2022).
  • Patel D , PotterM, AnayaJMet al. Kynurenine induces an age-related phenotype in bone marrow stromal cells. Mech. Ageing Dev.195, 111464 (2021).
  • Kim BJ , HamrickMW, YooHJet al. The detrimental effects of kynurenine, a tryptophan metabolite, on human bone metabolism. J. Clin. Endocrinol. Metab.104(6), 2334–2342 (2019).
  • Apalset EM , GjesdalCG, UelandPMet al. Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study. Clin. Exp. Immunol.176(3), 452–460 (2014).
  • Miyamoto K , HirayamaA, SatoYet al. A metabolomic profile predictive of new osteoporosis or sarcopenia development. Metabolites11(5), 278 (2021).
  • Zhang X , XuH, LiGHet al. Metabolomics insights into osteoporosis through association with bone mineral density. J. Bone Miner. Res.36(4), 729–738 (2021).
  • Pernow Y , ThorénM, SääfMet al. Associations between amino acids and bone mineral density in men with idiopathic osteoporosis. Bone47(5), 959–965 (2010).
  • Eriksson AL , FriedrichN, KarlssonMKet al. Serum glycine levels are associated with cortical bone properties and fracture risk in men. J. Clin. Endocrinol. Metab.106(12), e5021–e5029 (2021).
  • Jennings A , MacGregorA, SpectorT, CassidyA. Amino acid intakes are associated with bone mineral density and prevalence of low bone mass in women: evidence from discordant monozygotic twins. J. Bone Miner. Res.31(2), 326–335 (2016).
  • Kim MH , KimHM, JeongHJ. Estrogen-like osteoprotective effects of glycine in in vitro and in vivo models of menopause. Amino Acids48(3), 791–800 (2016).
  • Li X , LinQ, CuiYet al. Glycine acts through estrogen receptor alpha to mediate estrogen receptor signaling, stimulating osteogenesis and attenuating adipogenesis in ovariectomized rats. Molecular Nutr. Food Res.66(11), e2100857 (2022).
  • Wang J , YanD, ZhaoAet al. Discovery of potential biomarkers for osteoporosis using LC–MS/MS metabolomic methods. Osteoporos. Int.30(7), 1491–1499 (2019).
  • Cipriani C , ColangeloL, SantoriRet al. The interplay between bone and glucose metabolism. Front. Endocrinol.11, 122 (2020).
  • Zhang D , DuJ, YuM, SuoL. Urine-derived stem cells–extracellular vesicles ameliorate diabetic osteoporosis through HDAC4/HIF-1α/VEGFA axis by delivering microRNA-26a-5p. Cell Biol. Toxicol. doi:10.1007/s10565-022-09713-5 (2022) ( Epub ahead of print).
  • Jianhong W , WangtaoD, MinSet al. The mechanism of hypoxia–hyperglycemia axis in diabetic osteoporosis. Chinese Journal of Osteoporosis28(11), 1634–1639 (2022).
  • Kang L , ChenCH, ChengYCet al. Glucosamine-induced insulin resistance in ovariectomized rats is relevant to decreasing the expression of glucose transport protein subtype 4 in the skeletal muscle and in increasing the size of pancreatic islets. Menopause19(5), 496–502 (2012).
  • Liu G , ShiF, Blas-MachadoUet al. Dietary galactose inhibits GDF-9 mediated follicular development in the rat ovary. Reprod. Toxicol.21(1), 26–33 (2006).
  • Fangjie W , TingW, FangmeiL, ChuanxiangZ, ShaoL. Study on anti-osteoporosis effect of Eucommiae Cortex based on GC–MS metabonomics. Zhongguo Zhong Yao Za Zhi45(22), 5555–5560 (2020).
  • Zheng Y , LuQ, HuangD, XieP. Protective effects of taurine treatment on bone mass and bone strength in aged rats through activation of autophagy. Chinese Journal of Osteoporosis27(1), 91–95+109 (2021).
  • Yuan LQ , LuY, LuoXH, XieH, WuXP, LiaoEY. Taurine promotes connective tissue growth factor (CTGF) expression in osteoblasts through the ERK signal pathway. Amino Acids32(3), 425–430 (2007).
  • Liu G , XiaQ, SongN, HuoH, HongW, LiaoJ. Role of pyruvic acid in osteoclast differentiation. Chinese Journal of Tissue Engineering Research27(31), 5015–5021 (2023).
  • Qi H , BaoJ, AnGet al. Association between the metabolome and bone mineral density in pre- and post-menopausal Chinese women using GC–MS. Mol. Biosyst.12(7), 2265–2275 (2016).
  • Tu Y , YangR, XuX, ZhouX. The microbiota–gut–bone axis and bone health. J. Leukoc. Biol.110(3), 525–537 (2021).
  • Lucas S , OmataY, HofmannJet al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat. Commun.9(1), 55 (2018).
  • Greenbaum J , LinX, SuKJet al. Integration of the human gut microbiome and serum metabolome reveals novel biological factors involved in the regulation of bone mineral density. Front. Cell. Infect. Microbiol.12, 853499 (2022).
  • Tyagi AM , YuM, DarbyTMet al. The microbial metabolite butyrate stimulates bone formation via T regulatory cell-mediated regulation of WNT10B expression. Immunity49(6), 1116–1131.e1117 (2018).
  • Austermann K , BaeckerN, StehleP, HeerM. Putative effects of nutritive polyphenols on bone metabolism in vivo – evidence from human studies. Nutrients11(4), 871 (2019).
  • Law M , MaWK, ChanEet al. Cumulative effective dose and cancer risk of pediatric population in repetitive whole-body scan using dual-energy x-ray absorptiometry. J. Clin. Densitom.22(1), 52–58 (2017).
  • Tan A , ZengX, WangLet al. Osteoporosis detection in lumbar spine by QCT and DXA: a meta-analysis. Chinese Journal of Osteoporosis28(10), 1434–1441 (2022).
  • Aibar-Almazán A , Voltes-MartínezA, Castellote-CaballeroY, Afanador-RestrepoDF, Carcelén-FraileMDC, López-RuizE. Current status of the diagnosis and management of osteoporosis. Int. J. Mol. Sci.23(16), 9465 (2022).
  • Kirwan JA , BrennanL, BroadhurstDet al. Preanalytical processing and biobanking procedures of biological samples for metabolomics research: a white paper, community perspective (for “Precision Medicine and Pharmacometabolomics Task Group” – the Metabolomics Society initiative). Clin. Chem.64(8), 1158–1182 (2018).
  • Hayton S , MakerGL, MullaneyI, TrengoveRD. Experimental design and reporting standards for metabolomics studies of mammalian cell lines. CMLS74(24), 4421–4441 (2017).
  • Bi H , GuoZ, JiaX, LiuH, MaL, XueL. The key points in the pre-analytical procedures of blood and urine samples in metabolomics studies. Metabolomics16(6), 68 (2020).
  • Rampler E , AbieadYE, SchoenyHet al. Recurrent topics in mass spectrometry-based metabolomics and lipidomics-standardization, coverage, and throughput. Anal. Chem.93(1), 519–545 (2021).
  • Wang Z , LiX, AblizZ. Chemical derivatization for mass spectrometric analysis of metabolite isomers. Progress in Chemistry33(3), 406–416 (2021).
  • Lu L , TangM, LiJet al. Gut microbiota and serum metabolic signatures of high-fat-induced bone loss in mice. Front. Cell. Infect. Microbiol.11, 788576 (2021).
  • He J , XuS, ZhangBet al. Gut microbiota and metabolite alterations associated with reduced bone mineral density or bone metabolic indexes in postmenopausal osteoporosis. Aging12(9), 8583–8604 (2020).
  • You YS , LinCY, LiangHJet al. Association between the metabolome and low bone mineral density in Taiwanese women determined by (1)H NMR spectroscopy. J. Bone Miner. Res.29(1), 212–222 (2014).
  • Watanabe K , IidaM, HaradaSet al. Metabolic profiling of charged metabolites in association with menopausal status in Japanese community-dwelling midlife women: Tsuruoka Metabolomic Cohort Study. Maturitas155, 54–62 (2022).
  • Aleidi SM , AlnehmiEA, AlshakerMet al. A distinctive human metabolomics alteration associated with osteopenic and osteoporotic patients. Metabolites11(9), 628 (2021).